Gynoxin Uno (Fenticonazole Nitrate)

Gynoxin Uno is indicated for the topical treatment of fungal infections affecting the female genital tract.

• Vulvovaginal candidiasis caused by Candida species.
• Acute vaginal yeast infection presenting with itching, burning, and discharge.
• Recurrent vaginal candidiasis as part of a maintenance regimen.
• Mixed fungal infections of the vagina when identified by laboratory testing.

Adverse reactions to Gynoxin Uno are generally mild, but serious events can occur rarely.

Common

• Local irritation or burning at the application site.
• Vaginal itching or mild discomfort.
• Unusual vaginal discharge with a mild odor.
• Headache.

Serious

• Severe allergic reaction such as rash, swelling, or difficulty breathing.
• Persistent or worsening vaginal symptoms despite treatment.
• Signs of secondary bacterial infection (fever, pelvic pain).
• Liver enzyme abnormalities (rare).

Before using Gynoxin Uno, certain precautions should be considered to ensure safe and effective therapy.

• Confirm diagnosis of a fungal infection before initiating therapy.
• Avoid use if you have a known hypersensitivity to fenticonazole or other imidazole antifungals.
• Do not use during active vaginal bleeding or after recent vaginal surgery without medical advice.
• Discuss pregnancy or breastfeeding status with a healthcare professional, as safety data are limited.
• Inform your clinician about any chronic medical conditions, especially liver disease.
• Follow the prescribed dosing schedule and complete the full course of treatment.

Gynoxin Uno may interact with other medications or substances applied vaginally.

Avoid

• Concurrent use of other intravaginal antifungal or antiseptic products unless directed by a clinician.
• Systemic azole antifungals (e.g., fluconazole) without medical supervision, as additive antifungal effects may increase toxicity.

Use with caution

• Hormonal contraceptives administered vaginally, as local irritation could affect absorption.
• Topical corticosteroids applied to the vagina, which may mask signs of infection.
• Systemic medications metabolized by hepatic enzymes that could be affected by imidazole compounds (e.g., certain statins).